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Abstract
Objective: To study the prevelence of antibiotic resistance and the prevalent bacterial
isolates in hospitalized patients in Khartoum hospitals.
Materials & Methods: A cross-sectional prevalence study was carried out during the
period of April–November 2015 in Khartoum; 226 bacterial cultures were included.
Identiﬁcation of isolates using standard biochemical tests and antibiotic susceptibilities
were determined using disc diffusion method. Results were interpreted according to
the standards of the British society of antimicrobial chemotherapy.
Results: Eight bacterial species were isolated: Staphylococcus aureus, Enterococcus
faecalis, Streptococcus spp., Klebsiella pneumoniae, Pseudomonas spp., Escherichia
coli, Proteus spp., and Acinetobacter spp. S. aureus was the most prevalent, the
majority of which were resistant to methicillin/oxacillin (MRSA). Cultures in our study
were mainly from urine (36.7%), blood samples (37.2%), and wound cultures (19%).
More than 90% of the tested isolates were resistant to cefuroxime; 54% and 73.8% of
Gram-positive and Gram-negative isolates, respectively, were resistant to ceftazidime.
Furthermore, there was a high meropenem resistance among Gram-negative isolates
tested. Multi-resistant Acinetobacter spp. as well as vancomycin-resistant S. aureus
was isolated. Gram-negative isolates showed good susceptibilities to aminoglycosides
as well as ciproﬂoxacin. However, the high resistance rate to these antibiotics was
observed in Gram-positive isolates in these hospitals.
Conclusion: Methicillin-resistant S. aureus was the most prevalent organism. Gram-
negative isolates showed good susceptibilities to aminoglycosides and ciproﬂoxacin.
There were high resistance rates to cefuroxime, ceftazidime, and meropenem. Five
vancomycin-resistant S. aureus were identiﬁed.
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1. Introduction
The worldwide spread of bacterial resistance to antimicrobial agents may limit the future
progress of medicine. A huge environmental antibiotic pressure, resulting from industrial
production andmarketing of these drugs, has simultaneously contributed to the increase
in the diversity of resistant phenotypes, to the selection of the ﬁttest among them, and
to the spreading of resistance genes. The antimicrobial resistance is recognized as
global crises, and in 2012, WHO Patient Safety launched a book, The evolving threat
of antimicrobial resistance - Options for action.
In Sudan, few studies were performed to assess the problem of antibiotic resistance
which we expect to be a major one as antibiotics use is not under control, and infection
control measures are not regularly practiced in hospitals [1]. The aim of this study
was to study the frequency of antibiotic-resistant bacteria and to identify the most
prevalent organisms causing hospital infections in four hospitals in Khartoum state. We
also studied the prevalence of multi-resistant bacteria in the hospitals included in the
study.
2. Materials and Methods
Ethical approval was obtained from the Ministry of Health Khartoum, Sudan. A cross-
sectional study was conducted.
2.1. Sampling procedure
The samples included bacteria grown on media. The sample frame composed of all
positive cultures during the study period. Systematic random sampling was used to
select the sample.
2.2. Patients and samples
The study was carried out in four tertiary hospitals in Khartoum, Sudan.
Samples (blood in case of sepsis or from other sites of infection) were collected by the
hospital staff upon the development of infection. When bacterial growth was conﬁrmed
by the microbiology laboratories at the hospital, the species were identiﬁed and stored
at –80ºC until further use. The isolates were identiﬁed using basic biochemical identiﬁ-
cation tests according to the Clinical and Laboratory Standards Institute [2, 3]. Antibiotic
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susceptibility testing was performed using the disc diffusion method according to the
British Society for Antimicrobial Chemotherapy (BSAC) [4, 5].
A database was set up to record the data associated with the bacterial sample.
3. Results
During the period between April and November 2015, 622 positive cultures were grown
in the four different hospitals under study (Soba University hospital, Omdurman pediatric
hospital, Reibat hospital, and Bahri teaching hospital).
Two hundred and twenty-eight isolates were selected by a systematic random strat-
iﬁed method from hospitals’ microbiology laboratories.
Isolates were recovered from different clinical samples, collected from hospitalized
patients with clinical symptoms and signs of infection.
The phenotypic identiﬁcation revealed mainly eight bacterial species (spp.) including
Staphylococcus aureus, Enterococcus faecalis, Streptococcus spp. (Figure 1), Klebsiella
pneumoniae, Pseudomonas spp., Escherichia coli, Proteus spp., and Acinetobacter spp
(Figure 2).
Soba university hospital and Reibat hospital laboratories are the only hospitals in
our study that performed blood cultures. All four microbiology laboratories processed
different clinical samples such as urine, wound swabs, sputum, body ﬂuids, and swabs
from the upper respiratory tract. Gram-positive bacteria mainly S. aureus and S. faecalis
were the most frequent isolates from all sites of infection. Gram-negative bacilli were
mainly isolated from blood and urine cultures.
Analysis of the antibiotic susceptibility pattern among the isolates in the study had
shown a high resistance rate to many 𝛽-lactam antibiotics. The highest resistance
rate was found to be to amoxicillin, followed by cefoxitin, cefuroxime, and ampicillin,
respectively (Tables 1 and 2).
Staphylococcus aureus was the most prevalent organism causing infections in all
the hospitals studied (Figure 1). The majority of S. aureus isolates were resistant to
methicillin/oxacillin (MRSA), which indicates their multi-resistant phenotype. Infection
with MRSA was highest among Omdurman hospital patients where 80% of the S.
aureus isolates were MRSA. Alarmingly, vancomycin-resistant S. aureus (VRSA) isolates
were found in two of the hospitals under study and multi-resistant Acinetobacter spp.
as well as carbapenem (meropenem)-resistant Gram-negative bacteria were isolated
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in one hospital. Twenty percent of the Gram-negative isolates tested for meropenem
susceptibility was resistant to this antibiotic.
Gram-negative isolates from all four hospitals showed good susceptibilities to amino-
glycosides such gentamycin and amikacin as well as the ﬂuoroquinolone, ciproﬂoxacin
(Table 2). However, a high resistance rate was observed in Gram-positive isolates in
these hospitals (Table 1).
Table 1: Antibiotic susceptibility pattern among Gram-positive isolates.
Antibiotic % Susceptible Isolates % Resistant Isolates
Vancomycin 92.8 7.2
Gentamycin 79.3 20.7
Ceftriaxone 73.9 26.1
Amikacin 67.7 32.3
Cefotaxime 54.2 45.8
Ciproﬂoxacin 59.3 40.7
Ceftazidime 45.9 54.1
Erythromycin 38.2 61.8
Oxacillin/methicillin 38.1 61.9
Trimethoprim-sulfamethoxazole 36.7 63.3
Amoxicillin-clavulanate 35.7 64.3
Ampicillin 25 75
Table 2: Antibiotic susceptibility pattern among Gram-negative isolates.
Antibiotic % Susceptible Isolates % Resistant Isolates
Colistin 100 0
Amikacin 92.5 7.5
Meropenem 79.8 20.2
Gentamycin 77.6 22.4
Ceftriaxone 63.2 36.8
Ciproﬂoxacin 62.2 37.8
Trimethoprim-
sulfamethoxazole
33.7 66.3
Ceftazidime 26.2 73.8
Piperacillin-tazobactam 14.7 85.3
Cefuroxime 5.3 94.7
Cefoxitin 5.1
Ampicillin/amoxicillin 1 99
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Figure 1: Gram-positive bacteria cultured from hospitalized infected patients over an eight-months period
with S. aureus being the most common in all four hospitals.
Figure 2: Klebsiella pneumoniae was the most prevalent Gram-negative isolate during the study period
and Acinetobacter spp. was the least prevalent.
4. Discussion
The majority of positive cultures in this study were isolated from patients with urinary
tract infections (UTI) (36.7%) and blood samples from patients with bloodstream infec-
tions. UTI, particularly catheter-associated urinary tract infections (CAUTIs) were shown
to account for approximately 40% of all healthcare-associated infections [7]. Despite
studies showing the beneﬁt of interventions for the prevention of CAUTI, the adoption
of these practices has not occurred in many hospitals in Sudan.
The most frequent pathogens causing healthcare-associated UTI include E. coli, P.
aeruginosa, enterococci, and Candida albicans; in our study, UTI was mainly caused
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by K. pneumoniae, S. aureus, E. coli, E. faecalis, Pseudomonas spp., and Proteus spp.
Studies have shown that both the species distribution and rates of resistance vary
considerably among the institutions and regions [7, 8].
The second highest culture-positive rate in this study was observed in blood cultures
that have very serious implications as shown in former studies. It is well recognized that
hospital-acquired severe sepsis was associated with both higher mortality and resource
utilization than community-acquired severe sepsis [9].
Cultures from wounds, including surgical site infections (SSIs), were the third frequent
positive cultures in this study (19%). SSIs are a major contributor to the morbidity and
mortality in postsurgical care. The risk for SSIs is multifactorial and includes a host of
microbial, patient-related, and procedure-related factors [10].
The incidence of SSI was shown to be as high as 20%, depending on the surgical
procedure, the surveillance criteria used, and the quality of data collection. In many SSIs,
the responsible pathogens originate from the patient’s endogenous ﬂora. The causative
pathogens depend on the type of surgery; the most commonly isolated organisms are
S. aureus, coagulase-negative staphylococci, Enterococcus spp., and E. coli [11]. In the
current study, wound infections, including SSIs, were frequently caused by S. aureus,
the majority of which were MRSA.
High prevalence of MRSA is a major problem identiﬁed in this study and needs to be
addressed urgently. Methods such as screening for colonization with MRSA is needed
as it has been shown to increase the risk of infection [12–14].
VRSA was identiﬁed in two hospitals. The emergence of VRSA emphasizes the high
need for programs to prevent the spread of antimicrobial-resistant microorganisms and
control the use of antimicrobial drugs in healthcare settings.
Multi-resistant Acinetobacter spp. was isolated in the intensive care unit-hospitalized
patients in one of the hospitals studied. Acinetobacter spp. was grown from different
infection sites. Since the 1970s, the spread of multidrug-resistant (MDR) Acinetobac-
ter strains among critically ill, hospitalized patients, and subsequent epidemics, have
become an increasing cause of concern. Before the 1970s, Acinetobacter infections
were mostly post-surgical UTI in patients hospitalized in surgical units. The signiﬁcant
improvement in resuscitation techniques during the last 30 years has changed the types
of infection caused by Acinetobacter spp. and since the 1980s, it has spread rapidly
among patients in intensive care units [15, 16].
The isolates in the present study exhibited high resistance rates to many antibiotics
including cephalosporin and carbapenem antibiotics. Resistance to ceftazidime ranged
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from 54.1% to as high as 73.8% in some hospitals. The presence of the extended 𝛽-
lactamase CTX-M is likely in these isolates [17, 18].
The very high rate of resistance to amoxicillin (99%) amongst the isolates in the
current study is very alarming. The probability of spread of a resistant clone should be
investigated.
High resistance to meropenem was found in Gram-negative isolates under study
that must be handled seriously as carbapenem resistance spreads rapidly and causes
challenges in treatment, resulting in high mortality and morbidity rates. It is necessary to
observe the use of these antibiotics and to take essential infection control precautions
to avoid the spread of this resistance [19–22].
5. Conclusions
• Staphylococcus aureuswas themost prevalent organism all the hospitals studied.
The majority of S. aureus isolates were MRSA.
• Gram-negative isolates from all four hospitals showed good susceptibilities to
gentamycin and amikacin as well as ciproﬂoxacin. However, a high resistance
rate was observed in Gram-positive isolates in these hospitals.
• There are high resistance rates to cefuroxime and ceftazidime. High carbapenem
resistance was found amongst Gram-negative isolates.
• Five VRSA were identiﬁed.
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